Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

Published:2017-01-17 Issue:1 Volume:12 Page:e0169951
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Xu Haiyan,Wang Bingjian,Yang Jing,Ma Shuren,Xie Xiongwei^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;GN Levine;Circulation,2016

2. Anticoagulant therapy for percutaneous coronary intervention;SV Rao;Circ Cardiovasc Interv,2010

4. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction;BA Vakili;Circulation,2001

5. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry;H Benamer;EuroIntervention,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis;Side Effects of Drugs Annual;2018

2. Exploration of Bivalirudin Use during Percutaneous Coronary Intervention for High Bleeding Risk Patients with Chronic Total Occlusion;International Heart Journal;2018